Steven R. Hagen, SVP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 3,750 shares at $16.22 ($61K) on 2015-02-23, disclosed to the SEC on 2015-02-25.
Seasonal sale ($61k) by SVP Pharmaceutical Development & Mfg — this insider has traded AMRI in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |